Figure 3From: Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report Liquor sample evaluation. (A) Hematoxylin and eosin staining; (B) HMB45 immunocytochemistry; (C) S100 immunocytochemistry.Back to article page